程柯：修订间差异

<br>Dr. Ke Cheng is a Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine in the Department of Molecular Biomedical Sciences at NC State University and in the UNC/NCSU joint Department of Biomedical Engineering. He is an adjunct professor at the UNC Eshelman School of Pharmacy. He also serves as the co-director of the functional tissue engineering program at the Comparative Medicine Institute. Dr. Cheng’s formal education began with a B.S. degree in Pharmaceutical Engineering from Zhejiang University, followed by a Ph.D. degree in Biological Engineering from University of Georgia and post-graduate training and junior faculty experiences at UCLA School of Medicine and Cedars-Sinai Medical Center. Dr. Cheng’s research has been published in journals like Lancet, Nature BME, Nature Comms, Science Advances, J of Clinical Investigation, Circulation, Circulation Research, Biomaterials and others. His work has been directly translated into two successful Investigational New Drug (IND) applications and licensed to several biotech companies. Dr. Cheng is Associate Editor of J Cell Mol Med and editorial board member of Circulation Research. He is a Fellow of AIBME and AHA. He is also a chartered member of the NIH BMBI Study Section (2019-2023).

<br>https://cvm.ncsu.edu/directory/cheng-ke/